Risk assessment with gut microbiome and metabolite markers in NAFLD development.
Leung H, Long X, Ni Y, Qian L, Nychas E, Siliceo SL, Pohl D, Hanhineva K, Liu Y, Xu A, Nielsen HB, Belda E, Clément K, Loomba R, Li H, Jia W, Panagiotou G.
Leung H, et al. Among authors: liu y.
Sci Transl Med. 2022 Jun 8;14(648):eabk0855. doi: 10.1126/scitranslmed.abk0855. Epub 2022 Jun 8.
Sci Transl Med. 2022.
PMID: 35675435
Free PMC article.